SEC Form 4 · accession 0001615774-17-001186
Emmaus Life Sciences, Inc. · EMMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Pappajohn
Director · 10% Owner
Period of report
Mar 21, 2017
Accepted (ET)
Mar 22, 2017 · 6:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000822370
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 21, 2017 | A | 40,000 | $6.25 | A | 496,412 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Purchased in a private placement of securities by the issuer.